A Randomized, Double-Blinded, Placebo-Controlled Protocol of Oral Cyclosporine in Patients With Advanced Stage Chronic Obstructive Pulmonary Disease

Trial Profile

A Randomized, Double-Blinded, Placebo-Controlled Protocol of Oral Cyclosporine in Patients With Advanced Stage Chronic Obstructive Pulmonary Disease

Active, no longer recruiting
Phase of Trial: Phase I/II

Latest Information Update: 01 Feb 2016

At a glance

  • Drugs Ciclosporin (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Jan 2016 Planned End Date changed from 1 Dec 2013 to 1 Dec 2016, according to ClinicalTrials.gov record.
    • 04 Jan 2016 Planned primary completion date changed from 1 Dec 2013 to 1 Dec 2016, according to ClinicalTrials.gov record.
    • 20 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top